WuXi Biologics Posts Strong 2024 Results, Forecasts Rapid Growth in 2025
March 25, 2025 | 17:30
WuXi Biologics (Cayman) Inc., a leading global Contract Research, Development and Manufacturing Organization service company offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to announce its audited annual results for the year ended December 31, 2024.
Mobile Version
